A wave of misinformation about the Human Papillomavirus (HPV) and cervical cancer has been circulating online recently, sparking confusion, fear and unnecessary stigma. In response, the ROSE Foundation is stepping forward to set the record straight with clear, evidence-based facts.
Founded in 2019, the ROSE Foundation has been at the forefront of revolutionising cervical cancer prevention in Malaysia. Its flagship ROSE programme empowers women with a simple, painless and private self-sampling test for HPV, paired with laboratory testing and digital follow-up.This innovative approach sets a new benchmark for women’s healthcare not only in Malaysia but across the Asean region.
